Bone Loss Drugs Increase Stroke Risk in Patients With Cancer

Publication
Article
Oncology Nursing NewsDecember 2010
Volume 4
Issue 6

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with her hair pulled back in front of a dark blue background
Photo of a woman with her hair in a ponytail in front of a light blue background
Image of a woman with gray hair on a light blue background